Page last updated: 2024-10-31

neostigmine and Coronary Heart Disease

neostigmine has been researched along with Coronary Heart Disease in 2 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
HERMANN, B1
CSEPPENTO, I1
IZSAK, T1
Ferrara, N1
Bonaduce, D1
Abete, P1
Leosco, D1
Caccese, P1
Tuccillo, B1
Longobardi, G1
Canonico, V1
Rengo, F1

Other Studies

2 other studies available for neostigmine and Coronary Heart Disease

ArticleYear
Reflex erythema studies in coronary disease.
    Acta medica Academiae Scientiarum Hungaricae, 1958, Volume: 11, Issue:2

    Topics: Acetylcholine; Coronary Disease; Erythema; Humans; Neostigmine; Nervous System Physiological Phenome

1958
[Role of the increased cholinergic activity in prevention of reperfusion-induced arrhythmia in dog experiments].
    Cardiologia (Rome, Italy), 1987, Volume: 32, Issue:4

    Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Dogs; Female; Heart Rate; Male; Neostigmine; Parasy

1987